EquityFlowCompanies › Genomics

Genomics

Biotech · Oxford, GB

Genomic risk-estimation tools for disease and cancer prevention.

Funding history

DateRoundAmount
Jan 2024Funding round
Oxford-based Genomics raised £35M led by F-Prime Capital and Foresight Partners for its genomic-prevention tools.
$44M

Investors

F-Prime CapitalForesight PartnersInfinity Investment PartnersMassMutual

Similar companies in Biotech

Explore funding flow on EquityFlow →